Hospitals

Rising threat of Multidrug-Resistant Sepsis in newborns at India’s District Hospitals: Study

A recent study conducted in five district hospitals across India has revealed alarming findings about the prevalence of sepsis in newborns. Published in The Lancet Global Health, the study highlights that a significant number of newborns admitted to Special Newborn Care Units (SNCUs) suffer from sepsis, with most cases being caused by multidrug-resistant bacteria.

Key Findings of the Study

The study included 6,612 newborns, out of which 3,357 (50.8%) showed clinical signs of sepsis.

Among them, 213 (3.2%) had confirmed culture-positive sepsis, with variations ranging from 0.6% to 10% across different hospitals.

The incidence of sepsis in outborn newborns (5.0%) was 2.5 times higher than in inborn newborns (2.0%).

The case-fatality rate was 36.6%, indicating a severe risk of death from sepsis.

Gram-negative bacteria accounted for 70% of infections, with Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp being the most common pathogens.

Rising Antibiotic Resistance: A Major Concern

The study further revealed that a significant proportion of the sepsis-causing bacteria were resistant to multiple antibiotics:

84.3% of Klebsiella pneumoniae, 84.8% of Escherichia coli, and 88.5% of Enterobacter spp were multidrug-resistant.

75% of Acinetobacter baumannii samples were also resistant to multiple antibiotics.

Need for Infection Control and Better Treatment Strategies

The researchers stressed the urgent need for improving infection control practices in district hospitals, establishing blood culture facilities, and implementing strict antibiotic stewardship programs.

Key Recommendations:

  1. Strengthening Infection Control: Improving hygiene and sanitation in hospitals.
  2. Mandatory Blood Culture Testing: Ensuring proper diagnosis before administering antibiotics.
  3. Responsible Antibiotic Use: Training healthcare professionals to use antibiotics judiciously to reduce resistance.

Government Policy and Future Action

The study emphasizes that the National Health Mission (NHM) and state governments should introduce dedicated programs to strengthen infection control measures in district hospitals.

This study was conducted by experts from the All India Institute of Medical Sciences (AIIMS) New Delhi, JIPMER Puducherry, AIIMS Raipur, Assam Medical College, and AIIMS Jodhpur and was funded by the Bill & Melinda Gates Foundation.

With newborn sepsis posing a significant threat to infant mortality in India, urgent steps are needed to address this growing challenge and prevent future outbreaks of multidrug-resistant infections.

Medlarge

Recent Posts

Kailash IVF marks one year of delivering advanced, personalized fertility care

Kailash IVF, the fertility centre under Kailash Healthcare, has completed asuccessful year of providing advanced,…

2 weeks ago

Breakthrough Defence technology SSI Vimana and Project Operion launched

 SS Innovations International, the maker of India’s first and only home-grown surgical robotic system, SSI…

2 weeks ago

Ayurvedic wellness brand Amma Living launched to bring traditional wisdom into everyday life

An Ayurvedic preventive wellness brand - Amma Living – has made its entry into India’s…

1 month ago

Cancer Awareness, Prevention and Screening camp held at Tis Hazari Court Complex

In an effort to promote early detection and prevention of deadly cancer among court staffs,…

2 months ago

Over 90% Glaucoma cases undiagnosed in India, experts at AbbVie Conclave

Nearly 90 per cent of glaucoma cases in India remain undiagnosed, experts warned at a…

2 months ago

Common among women of reproductive age-group, AIIMS warns of rising prevalence of autoimmune disease

The All India Institute of Medical Sciences on Wednesday flagged concern over a spurt in…

3 months ago